On March 11 JSC Olainfarm organized its fourth quarter 2014 Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of fourth quarter 2014 and non-audited financial results of 12 months 2014 and informed about the company’s future activities, paying extra attention to company’s home market – Latvia.

During the webinar Salvis Lapiņš said that with the aim to mitigate the effect the recession of Russia company continues to move its marketing effort into smaller regions of Russia. In 2015 minor sales increase is planned in Russia compared to 2014.

Answering to the question of loans given to Management, Salvis Lapiņš noted that repayment schedule is being developed and in around 3 years the loan should be repaid.

The recorded Olainfarm webinar is available online: bit.ly/1AjfhKU, and the presentation, demonstrated during the webinar, can be found here: Webinar Presentation: 4th quarter and entire 2014

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv